Our Work


The FIP Foundation supports and fosters research activities through grants, research incubation and the development of collaborative research partnerships among and between the Foundation and other FIP units such as sections, special interest groups, FIPEd, the Board of Pharmaceutical Practice, the Board of Pharmaceutical Sciences, and the Early Career Pharmaceutical Group (ECPG).


  1. Continue and expand the annual FIP Foundation and ECPG Innovation Research Grant
  2. Foster collaborative research partnerships between the Foundation and other FIP Units
  3. Identify contacts across FIP units who are involved or interested in collaborative research and form a Foundation Research Working group
  4. Define a Foundation research work plan that will expand our support of research across practice, education, and science.

Making a Difference: The Foundation and ECPG Innovation Research Grant:

The Foundation, together with the FIP ECPG, awards a grant of EUR 1,000 to encourage innovation in pharmacy by a young pharmacist or pharmaceutical scientist who has limited resources for their own research. The grant has been awarded annually since 2002 and supports the implementation of the recipient’s project. The recipient also receives travel support to attend the FIP World Congress and present project results.

To learn more about the Innovation Research Grant and application process, please click here.

Recent Grant Awards:

2022 Innovation Grant recipient, Brian Cicali of Florida, USA will conduct a project titled “Model-informed Evidence Approach for Pediatric and Neonate Dosing of Tramadol. Results will be reported at the 2023 FIP World Congress in September 2023.

2020 Innovation Grant recipient, Dallas Smith, at the College of Medicine, University of Malawi, implemented the initiative, entitled “Evaluation of a pharmacist led medication therapy management (MTM) program for patients with hypertension at an outpatient clinic”. “Ambulatory care pharmacists can make a substantial impact on hypertension outcomes and improve patient care; however, this type of service is yet to be implemented in Malawi. We aimed to quantify the influence an ambulatory pharmacist providing MTM services can have over a 12 month time period in a tertiary hospital’s hypertension clinic,” said Dr Smith. Results of the study found:

  1. Blood pressure improvements
  2. Patient Satisfaction improvements
  3. Healthcare Provider Feedback improvements